Company / Capital Returned to Shareholders per Share
Organon & Co. Capital Returned to Shareholders per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.34
FY2025
5-year range
$0.00 / $1.16
FY2021-FY2025
Trend
-70.6%
vs FY2024
Sector context
#35 of 51
Health Care
What the data says
At $0.34, Organon & Co.'s capital returned to shareholders per share ranks #35 of 51 in the Health Care sector. Declined from $1.16 to $0.34 over the past 2 years.
Based on SEC 10-K filings.
0.34 in FY2025 with a 3-year CAGR of -33.2%.
Declined from $1.16 to $0.34 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -33.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#35 of 51 in Health CareTop 69% of 51This company $0.34 Sector average $2.74
▼
-87.5% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 70.6% year-over-year.
- Ranks #35 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2024.
- Lowest capital returned to shareholders per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | -70.6% |
| FY2024 | $1.16 | +0.5% |
| FY2023 | $1.16 | +1.1% |
| FY2022 | $1.14 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026